Alternatives firm BlueMountain Capital Management has added two senior investors to its private assets group, the manager announced Monday.
The new hires — Ameya Agge and Matt Jameson — will source, evaluate, and execute private investments related to health care, according to BlueMountain, which manages more the $21 billion.
“Just as the financial series industry went through a major transition in recent years, many health care sectors are beginning to go through substantial transformation that will dynamically evolve over the next decade, thus increasing the need for nontraditional capital providers,” BlueMountain chief investment officer and co-founder Andrew Feldstein said in a statement.
Both Agge and Jameson will report to private health care head Jim Pieri. The team has invested more than $500 million in health care in recent years, including in long-term care, behavioral health, acute care, and physician practice management companies.
“A combination or rising costs, ineffective delivery, and misaligned incentives are accelerating necessary market structure reform and business model change,” Pieri said in the statement. “As a result, the need for flexible capital solutions has increased substantially, creating a unique, persistent, and high barrier-to-access opportunity for our investors.”
Agge and Jameson are the latest in a string of additions BlueMountain has made to its portfolio company management team, which covers health care, specialty finance, and specialty situations. Earlier this year, Murtaza Ali, Jigar Shah, and Suraj Ramdas joined the team, which is led by Jon Weber.
The alternatives manager has also been expanding elsewhere, having added four portfolio managers earlier this month to focus on government-related strategies.
[II Deep Dive: BlueMountain Makes Four Hires for Global Governments Group]
Prior to joining BlueMountain, Agge was a partner at Apax Partners, specializing in private health care investments in the U.S. and Europe. Jameson, meanwhile, comes from Highland Capital Management, where he was a managing director and co-head of private equity.